资讯
The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...
The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...
The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.
The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...
COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果